Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://www.docguide.com/news/content.nsf/PaperFrameSet?OpenForm&id=03E05ADF052F2F3E852568C000807CA5&newsid=8525697700573E1885256CC200746041&u=GOTO//www3.interscience.wiley.com/cgi-bin/abstract/101521135/START&ref=

Wiley InterScience Home Page Personal Home Page Journal Finder Book Finder Search Wiley Interscience Reference Works Help Contact Us Logout
Article Abstract All Journals Previous Article Next Article acronym finder
About this Journal  

Online ISSN: 1520-7560    Print ISSN: 1520-7552
Diabetes/Metabolism Research and Reviews
Volume 19, Issue 1, 2003. Pages: 8-31

Articles Available Online in Advance of Print
Published Online: 2 Dec 2002
 

Copyright © 2002 John Wiley & Sons, Ltd.


Add to your Hot Article list
Enhanced Abstract Available
Article's Full Text in PDF
Article's Full Text in HTML

 Review Article
 

A new look at viruses in type 1 diabetes
Hee-Sook Jun, Dr Ji-Won Yoon *
Julia McFarlane Diabetes Research Centre and Department of Microbiology and Infectious Diseases, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
 
email: Ji-Won Yoon (yoon@ucalgary.ca)

*Correspondence to Ji-Won Yoon, Julia McFarlane Diabetes Research Centre, Faculty of Medicine, University of Calgary, 3330 Hospital Drive N.W., Calgary, Alberta T2N, 4N1 Canada.

These two authors contributed equally

 

Keywords
virus • type 1 diabetes • environmental factor • virus-mediated autoimmunity • beta cell-specific autoimmunity

 

Abstract
Type 1 diabetes (T1D) results from the destruction of pancreatic beta cells. Genetic factors are believed to be a major component for the development of T1D, but the concordance rate for the development of diabetes in identical twins is only about 40%, suggesting that nongenetic factors play an important role in the expression of the disease. Viruses are one environmental factor that is implicated in the pathogenesis of T1D. To date, 14 different viruses have been reported to be associated with the development of T1D in humans and animal models. Viruses may be involved in the pathogenesis of T1D in at least two distinct ways: by inducing beta cell-specific autoimmunity, with or without infection of the beta cells, [e.g. Kilham rat virus (KRV)] and by cytolytic infection and destruction of the beta cells (e.g. encephalomyocarditis virus in mice). With respect to virus-mediated autoimmunity, retrovirus, reovirus, KRV, bovine viral diarrhoea-mucosal disease virus, mumps virus, rubella virus, cytomegalovirus and Epstein-Barr virus (EBV) are discussed. With respect to the destruction of beta cells by cytolytic infection, encephalomyocarditis virus, mengovirus and Coxsackie B viruses are discussed. In addition, a review of transgenic animal models for virus-induced autoimmune diabetes is included, particularly with regard to lymphocytic choriomeningitis virus, influenza viral proteins and the Epstein-Barr viral receptor. Finally, the prevention of autoimmune diabetes by infection of viruses such as lymphocytic choriomeningitis virus is discussed. Copyright © 2002 John Wiley & Sons, Ltd.

Received: 25 March 2002; Revised: 19 August 2002; Accepted: 27 August 2002

 

Digital Object Identifier (DOI)


10.1002/dmrr.337  About DOI


 

References are available in the Enhanced Abstract


Additional Information


 


 

[Wiley InterScience Home Page] [Personal Home Page] [Journal Finder] [Book Finder] [Search Wiley InterScience] [Reference Works] [Help] [Contact Us][Logout]

Wiley InterScience is a member of CrossRef

CrossRef
 


Copyright © 1999-2003 by John Wiley & Sons, Inc. All rights reserved.
 

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.